Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZI-STOP: Azithromycin withdrawal in pediatric non-cystic fibrosis bronchiectasis
2014-003023-22Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin in bronchiectasis (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Time to first exacerbation. Started Jun 2015; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2014-003023-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003023-22.